Fufang Ejiao Syrup has shown promising clinical effectiveness and safety in treating the syndrome of Qi and blood defi-ciency in cancer-related fatigue.Expert consensus on clinical application of Fufang Ejiao Syrup in treating syndrome of Qi and blood de-ficiency in cancer-related fatigue was formulated by a panel of 33 multidisciplinary experts in Chinese and western clinical medicine,methodology,and pharmacy fields from China.They conducted a questionnaire survey among clinicians and systematically reviewed the existing literature on Fufang Ejiao Syrup.The consensus was grounded in the best available evidence,enriched by the experts' expe-rience.It has been reviewed and published by the China Association of Chinese Medicine,with the reference number GS/CACM 340-2023.The internationally recognized GRADE system was used to evaluate the evidence quality of the consensus,resulting in the deve-lopment of 7 recommendations and 20 consensus suggestions through the nominal group technique.The document outlined the indica-tions,traditional Chinese medicine diagnosis,timing of intervention,dosage,criteria for discontinuation,and safety profile of Fufang Ejiao Syrup for treating cancer-related fatigue.Finally,the consensus underwent extensive national consultation and peer review through expert meetings and correspondence reviews.This consensus is applicable to healthcare professionals at all levels of medical in-stitutions and serves as a reference for the rational use of drugs in clinical practices.
关键词
复方阿胶浆/癌因性疲乏/气血两虚证/专家共识
Key words
Fufang Ejiao Syrup/cancer-related fatigue/syndrome of Qi and blood deficiency/expert consensus
维普
万方数据